Zebrafish as a preclinical model for Extracellular Vesicle-based therapeutic development - Archive ouverte HAL Access content directly
Journal Articles Advanced Drug Delivery Reviews Year : 2021

Zebrafish as a preclinical model for Extracellular Vesicle-based therapeutic development

(1) , (1) , (1, 2)
1
2

Abstract

Extracellular Vesicles (EVs) are released during various pathophysiological processes and reflect the state of their cell of origin. Once released, they can propagate through biological fluids, target cells, deliver their content and elicit functional responses. These specific features would allow their harnessing as biomarkers, drug nano-vehicles and therapeutic intrinsic modulators. However, the further development of their potential therapeutic application is hampered by the lack of knowledge about how EVs behave in vivo. Recent advances in the field of imaging EVs in vivo now allow live-tracking of endogenous and exogenous EV in various model organisms at high spatiotemporal resolution to define their distribution, half-life and fate. This review highlights current imaging tools available to image EVs in vivo and how live imaging especially in the zebrafish embryo can bring further insights into the characterization of EVs dynamics, biodistribution and functions to potentiate their development for therapeutic applications.
Embargoed file
Embargoed file
Ne sera jamais visible

Dates and versions

inserm-03357931 , version 1 (29-09-2021)

Identifiers

Cite

Alexandre Androuin, Frederik Verweij, Guillaume van Niel. Zebrafish as a preclinical model for Extracellular Vesicle-based therapeutic development. Advanced Drug Delivery Reviews, 2021, 176, pp.113815. ⟨10.1016/j.addr.2021.05.025⟩. ⟨inserm-03357931⟩
28 View
28 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More